Ameritas Investment Partners’s Generation Bio GBIO Stock Holding History

Ameritas Investment Partners’s Portfolio GBIO Stock Details GBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-328	Closed	-$1.33K	–	3250
2025 Q1	$1.33K	Hold	328	–	–	﹤0.01%	3091
2024 Q4	$3.47K	Hold	328	–	–	﹤0.01%	3063
2024 Q3	$8.09K	Hold	328	–	–	﹤0.01%	2970
2024 Q2	$9.24K	Hold	328	–	–	﹤0.01%	2949
2024 Q1	$13.3K	Hold	328	–	–	﹤0.01%	2729
2023 Q4	$5.41K	Hold	328	–	–	﹤0.01%	2959
2023 Q3	$12.4K	Hold	328	–	–	﹤0.01%	2738
2023 Q2	$18K	Hold	328	–	–	﹤0.01%	2614
2023 Q1	$14.1K	Hold	328	–	–	﹤0.01%	2595
2022 Q4	$15.6K	Hold	328	–	–	﹤0.01%	2663
2022 Q3	$17K	Hold	328	–	–	﹤0.01%	2594
2022 Q2	$21K	Hold	328	–	–	﹤0.01%	2526
2022 Q1	$24K	Hold	328	–	–	﹤0.01%	2474
2021 Q4	$23K	Hold	328	–	–	﹤0.01%	2572
2021 Q3	$82K	Hold	328	–	–	﹤0.01%	1811
2021 Q2	$88K	Hold	328	–	–	﹤0.01%	1802
2021 Q1	$93K	Buy	328 +223	+212%	+$71.4K	﹤0.01%	1720
2020 Q4	$30K	Hold	105	–	–	﹤0.01%	2275
2020 Q3	$32K	Buy	+105	New	+$25.1K	﹤0.01%	2118

Other funds holding GBIO

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

AVLSA

Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Ameritas Investment Partners's GBIO Position: Q2 2025 in Review

Ameritas Investment Partners sold out of Generation Bio (GBIO) in Q2 2025, closing a stake of 328 shares — an estimated $1.33K sold.

Ameritas Investment Partners first reported a position in GBIO in Q3 2020 and held it in 19 quarters. The position peaked at $93K in Q1 2021. 61 funds tracked by Wall St. Rank hold GBIO as of Q2 2025.

Ameritas Investment Partners reported no remaining Generation Bio position as of Q2 2025 after selling out during the quarter.
Ameritas Investment Partners sold 328 Generation Bio shares in Q2 2025, an estimated $1.33K.
Ameritas Investment Partners first reported a position in Generation Bio in Q3 2020 and held it in 19 quarters.
Ameritas Investment Partners's Generation Bio position peaked at $93K in Q1 2021.
61 funds tracked by Wall St. Rank held Generation Bio as of Q2 2025.

Based on Ameritas Investment Partners's 13F filing for Q2 2025, filed 12 Aug 2025.